ClinicalTrials.gg
CompletedNCT07874230Updated Oct 14, 2026

Predictors of Pressure Pain Thresholds

An observational study in Office Worker, Myofascial Pain Syndrome (Upper Trapezius) and Pain Threshold, sponsored by Dokuz Eylul University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 25 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-14.

Sponsored by Dokuz Eylul University · Observational

Updated Oct 14, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
67
Ages
25 Years to 44 Years
Sex
All
01

Study summary

Objective: This cross-sectional study aimed to determine whether office-related strain risk, head and neck working posture, and weekly screen time predict the mean pressure pain threshold (PPT) at latent trigger points (LTrPs) in the upper trapezius muscle among office workers. A secondary aim was to examine relationships among LTrP characteristics, ergonomic risk factors, postural parameters, and demographic variables.

Inclusion criteria: Ages 25-44 years, BMI 18.5-29.9 kg/m², presence of at least one LTrP in the upper trapezius Exclusion criteria: Active trigger points, history of head/neck/shoulder surgery, pain medication use in last 24 hours, recent myofascial pain treatment Assessments Conducted: Demographics \& Time Variables: Age, gender, BMI, years of employment, weekly screen time (phone + computer), daily sitting time LTrP Identification: Manual pincer palpation by experienced physiotherapist (12 years experience) PPT Measurement: Calibrated Baseline Algometer at the most painful LTrP and a non-trigger point site Ergonomic Risk: Rapid Office Strain Assessment (ROSA)

Postural Assessment: Photogrammetry measuring:

Craniocervical Angle (CCA) Cervicothoracic Angle (CTA) All assessments were conducted one hour after participants started working to allow for postural adaptation.

Read the detailed description

Study Protocol Study Design This is a cross-sectional, observational study conducted at Dokuz Eylul University between October 2023 and August 2024. All procedures comply with the Declaration of Helsinki. Ethical approval was obtained from the Institutional Noninvasive Research Ethics Board (Approval number: 2023/31-23, Date: 4 October 2023). Written informed consent was obtained from all participants before data collection.

Participant Recruitment and Screening

Office workers at Dokuz Eylul University are recruited through workplace announcements. A two-stage screening process determines eligibility:

Inclusion Criteria:

Office workers aged 25-44 years

Body mass index (BMI) between 18.5 and 29.9 kg/m²

Presence of at least one latent trigger point (LTrP) in the upper trapezius muscle

Voluntary written informed consent

Exclusion Criteria:

History of head, neck, or shoulder surgery

Any condition that may be confused with myofascial pain (e.g., fibromyalgia, cervical radiculopathy)

Any condition altering pain sensation or tissue characteristics (e.g., neuropathy, diabetes)

Presence of an active trigger point (spontaneous pain) in the upper trapezius

Use of painkillers or anti-inflammatory drugs within 24 hours

Myofascial pain treatment within the last 3 months

BMI \< 18.5 or > 29.9 kg/m²

Pregnancy

Study Procedures All assessments are conducted one hour after participants begin their workday to allow for postural adaptation to their workspace. Each assessment session lasts approximately 40 minutes.

  1. Demographic and Time-Use Data Collection

    Age, sex, weight, height, and BMI are recorded

    Years of employment in office-based work are documented

    Weekly phone screen time is obtained from mobile device digital wellbeing trackers (Screen Time for iOS or Digital Wellbeing for Android)

    Weekly computer use time and daily sitting time are self-reported

    Total weekly screen time is calculated by combining phone and computer hours

  2. Latent Trigger Point Identification Participants receive brief education on differentiating active from latent trigger points. Those reporting spontaneous pain are excluded.

    Manual pincer palpation is performed bilaterally on the upper trapezius muscles by an experienced physiotherapist (12 years clinical experience, 5 years specializing in myofascial pain). Palpation follows the muscle from the nuchal line origin to the acromion insertion. An LTrP is confirmed by:

    Localized tenderness

    A palpable taut band

    A hypersensitive spot eliciting referred pain upon compression (without spontaneous symptoms)

    The most painful LTrP is marked with a permanent marker. A second palpation one minute later verifies the LTrP count; a third palpation is performed if discrepancies exist.

  3. Pressure Pain Threshold Assessment PPT is measured using a calibrated Baseline Algometer (10 kg/22 lbs., Fabrication Enterprises, USA). The probe is applied perpendicularly to the skin over the marked trigger point, with pressure increasing at approximately 1 kg/cm² per second. Participants verbally indicate pain onset; the reading is recorded in pounds. The algometer display is concealed from the examiner to prevent bias. The procedure is repeated three times at 30-second intervals, and the mean value is calculated. PPT is also assessed at a standardized non-trigger point area (no tenderness or taut bands) for comparison.
  4. Ergonomic Risk Assessment

    The Rapid Office Strain Assessment (ROSA) tool evaluates ergonomic risk factors including:

    Chair components (seat height, depth, armrests, back support)

    Monitor position (height, distance, angle)

    Telephone placement

    Keyboard and mouse positioning

    A cumulative score is generated; higher scores indicate greater ergonomic risk.

  5. Postural Assessment via Photogrammetry

Head and neck working posture is evaluated using photogrammetric measurement of:

Craniocervical Angle (CCA): Angle between the line connecting the lateral canthus to the tragus, and the line connecting the tragus to C7. Lower CCA indicates more pronounced forward head posture.

Cervicothoracic Angle (CTA): Angle between the line connecting the tragus to C7, and the line connecting C7 to the greater trochanter. Decreased CTA indicates increased thoracic kyphosis or combined forward head and rounded shoulder posture.

Procedure:

Participants wear open-necked clothing; hair is secured away from the face

Adhesive markers are placed on anatomical landmarks (right side preferred): lateral canthus, tragus, C7 spinous process, and greater trochanter

C7 is palpated following established protocols; the greater trochanter is palpated and marked

Participants resume their usual work tasks and undergo a 5-minute adjustment period to minimize the Hawthorne effect

Lateral photographs are captured three times at one-minute intervals from approximately 150 cm distance at acromion height using a tripod-mounted smartphone

Angle measurements are performed digitally using Adobe Acrobat DC; the mean of three measurements is used for analysis

The evaluator performing photographic measurements is blinded to all other participant data

Outcome Measures

Primary Outcome:

Mean Pressure Pain Threshold (PPT) at the most painful latent trigger point in the upper trapezius (measured in lbs/cm²)

Secondary Outcomes:

Number of LTrPs in the bilateral upper trapezius muscles

Mean PPT at non-trigger point site in the upper trapezius

Rapid Office Strain Assessment (ROSA) total score

Craniocervical Angle (CCA) in degrees

Cervicothoracic Angle (CTA) in degrees

Total weekly screen time (hours)

Daily sitting time (hours)

Years of employment in office-based work

Statistical Analysis Plan Sample Size: 67 participants who met all eligibility criteria.

Statistical Software: SPSS Statistics 26.0.

Data Distribution: Normality is assessed using the Kolmogorov-Smirnov test and descriptive statistics. All continuous variables are expected to follow normal distribution.

Primary Analysis:

Hierarchical multiple regression is performed to determine whether ROSA score and CTA predict mean PPT at LTrPs after controlling for demographic variables:

Step 1: Demographic variables (age, gender, BMI, years of employment)

Step 2: ROSA score and CTA added to the model

Significance level: p \< 0.05

Secondary Analyses:

Pearson correlation coefficients are calculated for relationships among PPTs, ROSA score, CCA, CTA, weekly screen time, daily sitting time, years of employment, and demographic variables

Spearman correlation coefficients are used for relationships involving the number of LTrPs

Correlation interpretation:

\<0.10: Negligible

0.10-0.39: Weak

0.40-0.69: Moderate

0.70-0.89: Strong

0.90-1.00: Very strong

Assumption Checking:

Multicollinearity is assessed using Variance Inflation Factor (VIF) and tolerance values. VIF \< 10 and tolerance > 0.2 indicate absence of multicollinearity.

02

Conditions studied

  • Office Worker
  • Myofascial Pain Syndrome (Upper Trapezius)
  • Pain Threshold
  • Trigger Points, Myofascial
  • Ergonomics
  • Ergonomic Risk and Work-related Musculoskeletal Characteristics in Blue- and White-collar Workers

Keywords

  • myofascial pain
  • office workers
  • latent
  • trigger points
  • determinants
  • pressure pain threshold
  • upper trapezius
  • ROSA
  • office strain
03

In context

Myofascial Pain Syndromes

1,143 studies on the registry are indexed under Myofascial Pain Syndromes; 137 are open to participants now.

This study's enrollment of 67 is below the median of 90 across 182 observational studies indexed under Myofascial Pain Syndromes.

Browse Myofascial Pain Syndromes studies →

Lead sponsor

Dokuz Eylul University is the lead sponsor of 257 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 44 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

office workers

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Office workers aged between 25 and 44 years Body mass index (BMI) between 18.5 and 29.9 kg/m² Presence of at least one latent trigger point (LTrP) in the upper trapezius muscle on either side Voluntary written informed consent

Exclusion criteria

Exclusion Criteria:

History of head, neck, or shoulder surgery History of any diagnosis or condition that may be confused with myofascial pain (e.g., fibromyalgia, cervical radiculopathy) Any diagnosis or condition that may alter pain sensation or tissue characteristics (e.g., peripheral neuropathy, diabetes mellitus) Presence of an active trigger point (spontaneous pain) in the upper trapezius muscle Use of painkillers or anti-inflammatory drugs within the last 24 hours Treatment for myofascial pain within the last 3 months BMI below 18.5 or above 29.9 kg/m² Pregnancy

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
67 participants (actual)
Patient registry
No

Groups and cohorts

  • office workers

    Office workers aged 25-44 years with BMI 18.5-29.9 kg/m² and at least one latent trigger point (LTrP) in the upper trapezius muscle. Participants were recruited from Dokuz Eylul University between October 2023 and August 2024. All participants were asymptomatic (no spontaneous pain in the upper trapezius) and had no history of head/neck/shoulder surgery, no conditions altering pain sensation, no active trigger points, no pain medication use in the last 24 hours, and no myofascial pain treatment in the last 3 months.

06

What researchers measure

Primary outcomes

  1. Mean Pressure Pain Threshold at Latent Trigger Points

    Time frame: baseline (single time point)

07

Study locations

1 site
  • Dokuz eylul university
    Izmir, balçova 35035, Turkey (Türkiye)
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07874230
Responsible party
Biron Onur Ugui (Dr., Izmir Katip Celebi University) — Principal investigator
First posted
Oct 14, 2026
Start date
Nov 4, 2023
Primary completion
Jul 4, 2025
Completion
Nov 4, 2025
Last update
Oct 14, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion